科研製薬の株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2021/08/27 | 5,050 | 5,070 | 4,960 | 4,990 | -70 | -1.4% | 129,900 |
2021/08/26 | 5,070 | 5,100 | 5,050 | 5,060 | -70 | -1.4% | 90,200 |
2021/08/25 | 5,180 | 5,180 | 5,080 | 5,130 | -100 | -1.9% | 88,400 |
2021/08/24 | 5,290 | 5,330 | 5,200 | 5,230 | -20 | -0.4% | 76,800 |
2021/08/23 | 5,200 | 5,300 | 5,200 | 5,250 | +80 | +1.5% | 106,600 |
2021/08/20 | 5,140 | 5,200 | 5,140 | 5,170 | +40 | +0.8% | 85,000 |
2021/08/19 | 5,030 | 5,140 | 5,030 | 5,130 | +130 | +2.6% | 120,600 |
2021/08/18 | 4,975 | 5,040 | 4,975 | 5,000 | +5 | +0.1% | 104,200 |
2021/08/17 | 4,965 | 5,020 | 4,965 | 4,995 | ±0 | ±0% | 61,800 |
2021/08/16 | 5,020 | 5,030 | 4,960 | 4,995 | -25 | -0.5% | 68,200 |
2021/08/13 | 4,975 | 5,040 | 4,970 | 5,020 | +80 | +1.6% | 103,700 |
2021/08/12 | 4,960 | 4,980 | 4,925 | 4,940 | -10 | -0.2% | 68,300 |
2021/08/11 | 4,925 | 4,960 | 4,905 | 4,950 | +15 | +0.3% | 77,900 |
2021/08/10 | 4,880 | 4,950 | 4,875 | 4,935 | +50 | +1% | 72,900 |
2021/08/06 | 4,870 | 4,900 | 4,850 | 4,885 | +15 | +0.3% | 54,600 |
2021/08/05 | 4,850 | 4,935 | 4,850 | 4,870 | -15 | -0.3% | 72,400 |
2021/08/04 | 4,885 | 4,950 | 4,870 | 4,885 | ±0 | ±0% | 99,000 |
2021/08/03 | 4,925 | 4,955 | 4,845 | 4,885 | -85 | -1.7% | 134,400 |
2021/08/02 | 4,900 | 4,970 | 4,895 | 4,970 | +135 | +2.8% | 118,300 |
2021/07/30 | 4,850 | 4,870 | 4,825 | 4,835 | +10 | +0.2% | 222,700 |
2021/07/29 | 4,880 | 4,895 | 4,815 | 4,825 | -80 | -1.6% | 78,700 |
2021/07/28 | 4,865 | 4,920 | 4,855 | 4,905 | -10 | -0.2% | 70,500 |
2021/07/27 | 4,930 | 4,935 | 4,895 | 4,915 | +20 | +0.4% | 83,400 |
2021/07/26 | 4,930 | 4,940 | 4,855 | 4,895 | +45 | +0.9% | 89,100 |
2021/07/21 | 4,845 | 4,875 | 4,815 | 4,850 | +15 | +0.3% | 92,100 |
2021/07/20 | 4,780 | 4,860 | 4,775 | 4,835 | +10 | +0.2% | 89,700 |
2021/07/19 | 4,785 | 4,845 | 4,780 | 4,825 | +10 | +0.2% | 85,100 |
2021/07/16 | 4,805 | 4,880 | 4,805 | 4,815 | -45 | -0.9% | 81,000 |
2021/07/15 | 4,895 | 4,960 | 4,840 | 4,860 | -10 | -0.2% | 118,900 |
2021/07/14 | 4,795 | 4,895 | 4,795 | 4,870 | +70 | +1.5% | 93,900 |
2021/07/13 | 4,815 | 4,830 | 4,800 | 4,800 | +5 | +0.1% | 76,400 |
2021/07/12 | 4,790 | 4,815 | 4,765 | 4,795 | +100 | +2.1% | 99,500 |
2021/07/09 | 4,640 | 4,715 | 4,630 | 4,695 | -15 | -0.3% | 125,500 |
2021/07/08 | 4,775 | 4,775 | 4,710 | 4,710 | -85 | -1.8% | 107,800 |
2021/07/07 | 4,760 | 4,795 | 4,725 | 4,795 | -25 | -0.5% | 104,500 |
2021/07/06 | 4,825 | 4,835 | 4,805 | 4,820 | +5 | +0.1% | 62,000 |
2021/07/05 | 4,860 | 4,895 | 4,815 | 4,815 | -45 | -0.9% | 96,000 |
2021/07/02 | 4,885 | 5,010 | 4,860 | 4,860 | +75 | +1.6% | 317,600 |
2021/07/01 | 4,760 | 4,815 | 4,750 | 4,785 | +25 | +0.5% | 97,900 |
2021/06/30 | 4,790 | 4,795 | 4,755 | 4,760 | -30 | -0.6% | 89,400 |
2021/06/29 | 4,790 | 4,815 | 4,765 | 4,790 | -45 | -0.9% | 79,800 |
2021/06/28 | 4,850 | 4,870 | 4,810 | 4,835 | +10 | +0.2% | 104,100 |
2021/06/25 | 4,840 | 4,850 | 4,790 | 4,825 | -5 | -0.1% | 91,800 |
2021/06/24 | 4,765 | 4,840 | 4,760 | 4,830 | +65 | +1.4% | 120,400 |
2021/06/23 | 4,755 | 4,810 | 4,755 | 4,765 | +5 | +0.1% | 115,700 |
2021/06/22 | 4,735 | 4,760 | 4,680 | 4,760 | +140 | +3% | 143,500 |
2021/06/21 | 4,650 | 4,665 | 4,605 | 4,620 | -120 | -2.5% | 129,700 |
2021/06/18 | 4,795 | 4,795 | 4,730 | 4,740 | -55 | -1.1% | 142,500 |
2021/06/17 | 4,770 | 4,810 | 4,765 | 4,795 | +40 | +0.8% | 108,500 |
2021/06/16 | 4,700 | 4,790 | 4,700 | 4,755 | ±0 | ±0% | 132,600 |
901~
950
件表示中 / 3692件
類似銘柄と比較する
現在ご覧いただいている「科研薬」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
科研薬 | 407,200円 | +30.5% | +111.0% | 4.67% | 11.48倍 | 1.00倍 |
|
旧理研グループの名門。導入の関節機能改善剤、自社創製の爪白癬症薬の2本柱。後発品も展開 |
日本新薬 | 373,500円 | +7.9% | +8.9% | 3.32% | 7.99倍 | 1.07倍 |
|
医家向け医薬品主体、自社創薬は泌尿器科、血液内科、難病・希少疾患に集中。機能食品も育成 |
サワイGHD | 203,300円 | +4.0% | +25.4% | 2.61% | 8.89倍 | 1.17倍 |
|
ジェネリック(後発)薬大手メーカー。21年春に沢井製薬が持株会社化。大型買収で米国本格展開 |
キッセイ薬 | 379,500円 | +14.5% | -2.3% | 2.37% | 13.88倍 | 0.74倍 |
|
医薬品中堅。泌尿器、腎・透析、未充足医療が重点領域。主軸特許切れ、新しい柱育成。海外は導出 |
サンバイオ | 229,900円 | - | - | 0.00% | - | 106.48倍 |
|
脳疾患向け再生細胞薬の開発・製造・販売目指すバイオベンチャー。米国で創業し日本に逆上陸 |
市場注目の銘柄
チャート関連のコラム